RESUMEN
BACKGROUND: Viral respiratory infections (VRIs) are a frequent cause of hospitalization in children under 24 months of age. A history of prematurity or heart disease may be a risk factor for complications in patients hospitalized for VRI. The objective was to describe epidemiological data for children hospitalized for IRV and aged 1 to 24 months and to identify risk factors for the presence of in-hospital complications and mortality over a period of 5 years. METHODS: This was a cross-sectional study. Patients registered with VRI codes B974, J12, J120-J129X, J168, J17, J171, J178, J20, J203-J209, J21, J210, J211, J218, J219 (based on International Classification of Diseases [ICD-10]) from 2013 to 2017 were included. Three subanalyses were performed to compare [1] patients with pathological history (prematurity, bronchopulmonary dysplasia [BPD] and congenital heart disease [CHD]), [2] diagnoses (pneumonia, acute bronchitis, and acute bronchiolitis), and [3] admission to the pediatric intensive care unit. Days of hospital stay, in-hospital complications, invasive medical procedure and mortality were analyzed. STATISTICAL ANALYSIS: VRI hospitalization prevalence was described. For comparison between groups, Student's t-test, ANOVA and the Chi2 test were applied. To identify factors related to days of hospital stay, in-hospital complications and mortality, a linear and logistic regression model was performed. RESULTS: A total of 66,304 hospitalizations were reported. The average age was 14.7 weeks; hospitalization events were higher in winter (39%), followed by autumn (27.3%). A total of 371 (0.56%) patients died. A total of 7068 (10.6%) hospitalized patients with pathological histories were identified. The presence of BPD (coefficient = 1.6), CHD (coefficient = 1.2), diagnosis of pneumonia (coefficient = 1.2), in-hospital complications (coefficient = 2.1) and invasive medical procedures (coefficient = 15.7) were the most common factors that increased the length of hospital stay. Risk factors for in-hospital complications and mortality were invasive medical procedure (OR = 3.3 & 11.7), BPD (OR = 1.8 & 1.6), CHD (OR = 4.6 & 3.4) and diagnosis of pneumonia (OR = 1.8 & 4.2). CONCLUSIONS: Risk factors for morbidity and mortality in patients hospitalized for VRIs are BPD and CHD, diagnosis of pneumonia and invasive medical procedure.
Asunto(s)
Bronquiolitis , Neumonía , Infecciones del Sistema Respiratorio , Virosis , Niño , Preescolar , Estudios Transversales , Hospitalización , Humanos , Lactante , Recién Nacido , Infecciones del Sistema Respiratorio/epidemiologíaRESUMEN
BACKGROUND: Type 2 diabetes mellitus (DM2) is a chronic disease, and for treatment to succeed, it is necessary to harmonize the mental health of the patient with the environment, which impacts quality of life and adherence to medical regimens. The objetive of this study is describe the quality of life of patients with DM2 and the factors relates to its modification. METHODS: This investigation was a cross-sectional study. Patients over 18 years of age with DM2 were selected. The following variables related to quality of life were studied: age, sex, occupation, marital status, years of DM2 evolution, comorbidities and presence of depression (Beck Depression Inventory). Perceived quality of life was measured with a health-related quality of life (HRQoL) scale, the 36-Item Short-Form Survey (SF-36). Patients were classified according to SF-36 HRQoL score (< 50, 51-75 and > 76 points). RESULTS: Among the 1394 patients included, the median age was 62 years. Global HRQoL had a median of 50.1 points. Bivariate analysis showed that age, marital status, sex, occupation, comorbidities, duration of DM2 and comorbidities had impacts on HRQoL. The logistic regression model identified age (odds ratio [OR] 1.04) and depression (OR 4.4) as independent factors that influenced overall quality of life. CONCLUSIONS: Patients with DM2 have poor HRQoL, which is associated with a high frequency of depression. Older age and the presence of depression impair patient HRQoL. TRIAL REGISTRATION: R-2013-781-052. Registered 20 December 2014.
Asunto(s)
Diabetes Mellitus Tipo 2/psicología , Calidad de Vida/psicología , Adulto , Factores de Edad , Anciano , Comorbilidad , Estudios Transversales , Depresión/complicaciones , Depresión/psicología , Diabetes Mellitus Tipo 2/complicaciones , Femenino , Encuestas Epidemiológicas , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Escalas de Valoración PsiquiátricaRESUMEN
Introduction: A history of pre-maturity may be a risk factor for complications in patients under 24 months of age hospitalized for viral respiratory infections (VRIs). Objective: To identify the impact of a history of pre-maturity on in-hospital complications and mortality in patients under 24 months of age who were hospitalized for VRIs over a period of 5 years. Material and Methods: This was a propensity score-matched study. The database was compiled by physicians, electronically validated by engineers, and analyzed by statisticians. Patients diagnosed with VRIs (based on International Classification of Diseases [ICD-10]) codes B974, J12, J120-J129X, J168, J17, J171, J178, J20, J203-J209, J21, J210, J211, J218, J219, J22X, and J189) from 2013 to 2017 were enrolled in the study. The subjects were classified into two groups according to the absence or presence of a history of pre-maturity (P070, P072, P073). Patients with congenital heart disease (CHD) (Q20-Q26) were excluded. Length of hospital stay, in-hospital complications, surgical procedures, and mortality were analyzed. Statistical Analysis: Patients were matched according to age. For comparisons between groups, Student's t-tests and chi2 tests were applied. A logistic regression model was constructed to identify factors related to in-hospital complications and mortality. Results: In total, 5,880 patients were eligible for inclusion in the analysis. The average patient age was 14.25 weeks. The presence of pre-maturity (coefficient = 1.16), male sex, bronchopulmonary dysplasia (BPD), in-hospital infectious complications (coefficient = 11.31), and invasive medical procedures (coefficient = 18.4) increased the number of days of hospitalization. Invasive medical procedures (OR = 6.13), a history of pre-maturity (OR = 2.54), and male sex (OR = 1.78) increased the risk for in-hospital complications. In-hospital infectious complications (OR = 84.2) and invasive medical procedures (OR = 58.4) were risk factors for mortality. Conclusions: A history of pre-maturity increased the length of hospital stay and the rate of in-hospital complications but did not increase mortality in patients under 24 months of age hospitalized for VRIs.
RESUMEN
Dengue manifestations range from a mild form, dengue fever (DF), to more severe forms such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). The ability of the host to present one of these clinical forms could be related to polymorphisms located in genes of the Toll-like receptors (TLRs) which activate the pro-inflammatory response. Therefore, the genotyping of single nucleotide genetic polymorphisms (SNPs) in TLR3 (rs3775291 and rs6552950), TLR4 (rs2737190, rs10759932, rs4986790, rs4986791, rs11536865, and rs10983755), TLR7 (rs179008 and rs3853839), and TLR8 (rs3764880, rs5741883, rs4830805, and rs1548731) was carried out in non-genetically related DHF patients, DF patients, and general population (GP) subjects. The SNPs were analyzed by real-time PCR by genotyping assays from Applied Biosystems®. The codominance model showed that dengue patients had a lower probability of presenting the TLR4-rs2737190-G/G genotype (odds ratio (OR) (95% CI) = 0.34 (0.14-0.8), p = 0.038). Dengue patients showed a lower probability of presenting TLR4-rs11536865-G/C genotype (OR (95% CI) = 0.19 (0.05-0.73), p = 0.0092) and had a high probability of presenting the TACG haplotype, but lower probability of presenting the TGCG haplotype in the TLR4 compared to GP individuals (OR (95% CI) = 0.55 (0.35-0.86), p = 0.0084). In conclusion, the TLR4-rs2737190-G/G and TLR4-rs11536865-G/C genotypes and TGCG haplotype were associated with protection from dengue.
Asunto(s)
Dengue/genética , Predisposición Genética a la Enfermedad , Polimorfismo de Nucleótido Simple , Receptor Toll-Like 3/genética , Receptor Toll-Like 4/genética , Receptor Toll-Like 7/genética , Receptor Toll-Like 8/genética , Adulto , Anciano , Alelos , Estudios de Casos y Controles , Dengue/sangre , Dengue/epidemiología , Epidemias , Femenino , Genotipo , Haplotipos , Humanos , Masculino , México/epidemiología , Persona de Mediana EdadRESUMEN
Background: There is a high risk of rejection of a corneal transplant known as a "rejection episode" in our Hospital conditioned by multiple variables. The aim of this article is to analyze the different risk factors of "corneal rejection episode" in post-transplant patients at one year of follow-up and in particular to consider the presence of donor blood incompatibility during the first year of post-surgical follow-up. Methods: A nested case-control study was designed in a cohort: observational, longitudinal, analytical and retrospective from year 2012 to 2013. We performed OR and logistic regression of the variables that influenced rejection. Results: We included 101 consecutive transplants from multiorgan donation. The variables that influenced the rejection episode were: preoperative high risk group, graft size, blood incompatibility, female gender and age over 60 years old. Other variables such as the presence of comorbidities, combined surgery, surgical time greater than one hour and postoperative complications did not show significant differences. Conclusions: It is advisable to perform routine blood compatibility to reduce the risk of rejection.
Introducción: Existe un elevado riesgo de rechazo de trasplante corneal conocido como "episodio de rechazo" en nuestro Hospital condicionado por múltiples variables. El objetivo de este trabajo fue analizar las diferentes causas de riesgo de episodio de rechazo corneal en pacientes postrasplantados a un año de seguimiento y en particular considerar la presencia con incompatibilidad sanguínea del donador durante el primer año de seguimiento posquirúrgico. Métodos: Se diseñó un estudio de casos y controles anidados en una cohorte: observacional, longitudinal, analítico y retrospectivo del año 2012 al 2013. Se realizó OR y regresión logística de las variables que influyeron en rechazo. Resultados: Se incluyeron 101 trasplantes consecutivos procedentes de donación multiorgánica. Las variables que influyeron en el episodio de rechazo fueron: grupo prequirúrgico de riesgo alto, tamaño del injerto, incompatibilidad sanguínea, género femenino y mayores de 60 años. Otras variables como la presencia de comorbilidades, cirugía combinada, tiempo quirúrgico mayor a una hora y complicaciones postquirúrgicas no mostraron diferencias significativas. Conclusiones: Es recomendable realizar de rutina la compatibilidad sanguínea para disminuir el riesgo de episodio de rechazo.